HIF in Gastric Cancer: Regulation and Therapeutic Target
- PMID: 35956843
- PMCID: PMC9370240
- DOI: 10.3390/molecules27154893
HIF in Gastric Cancer: Regulation and Therapeutic Target
Abstract
HIF means hypoxia-inducible factor gene family, and it could regulate various biological processes, including tumor development. In 2021, the FDA approved the new drug Welireg for targeting HIF-2a, and it is mainly used to treat von Hippel-Lindau syndrome, which demonstrated its good prospects in tumor therapy. As the fourth deadliest cancer worldwide, gastric cancer endangers the health of people all across the world. Currently, there are various treatment methods for patients with gastric cancer, but the five-year survival rate of patients with advanced gastric cancer is still not high. Therefore, here we reviewed the regulatory role and target role of HIF in gastric cancer, and provided some references for the treatment of gastric cancer.
Keywords: HIF; gastric cancer.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.Cancer Res. 2006 Jun 15;66(12):6264-70. doi: 10.1158/0008-5472.CAN-05-2519. Cancer Res. 2006. PMID: 16778202
-
Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells.Clin Cancer Res. 2003 Jan;9(1):433-40. Clin Cancer Res. 2003. PMID: 12538497
-
Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.Cancer Res. 2002 May 15;62(10):2957-61. Cancer Res. 2002. PMID: 12019178
-
Targeting HIF-1α signaling pathway for gastric cancer treatment.Pharmazie. 2019 Jan 1;74(1):3-7. doi: 10.1691/ph.2019.8674. Pharmazie. 2019. PMID: 30782242 Review.
-
The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis.Semin Cancer Biol. 2003 Feb;13(1):83-9. doi: 10.1016/s1044-579x(02)00103-7. Semin Cancer Biol. 2003. PMID: 12507560 Review.
Cited by
-
Matching traditional Chinese medicine and western medicine-based research: Advanced nutraceutical development for proactive gastric cancer prevention.World J Gastrointest Oncol. 2024 Sep 15;16(9):3798-3819. doi: 10.4251/wjgo.v16.i9.3798. World J Gastrointest Oncol. 2024. PMID: 39350981 Free PMC article. Review.
-
Targeting hypoxia-inducible factor-1 alpha suppresses Helicobacter pylori-induced gastric injury via attenuation of both cag-mediated microbial virulence and proinflammatory host responses.Gut Microbes. 2023 Dec;15(2):2263936. doi: 10.1080/19490976.2023.2263936. Epub 2023 Oct 13. Gut Microbes. 2023. PMID: 37828903 Free PMC article.
-
Deciphering the dual role of autophagy in gastric cancer and gastroesophageal junction cancer: from tumor suppression to cancer progression.Discov Oncol. 2025 Jun 5;16(1):1013. doi: 10.1007/s12672-025-02802-x. Discov Oncol. 2025. PMID: 40474010 Free PMC article. Review.
-
Adjuvant Properties of Caffeic Acid in Cancer Treatment.Int J Mol Sci. 2024 Jul 11;25(14):7631. doi: 10.3390/ijms25147631. Int J Mol Sci. 2024. PMID: 39062873 Free PMC article. Review.
-
A study related to the treatment of gastric cancer with Xiang-Sha-Liu-Jun-Zi-Tang based on network analysis.Heliyon. 2023 Aug 28;9(9):e19546. doi: 10.1016/j.heliyon.2023.e19546. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809372 Free PMC article.
References
-
- Xue X., Kang J.B., Yang X., Li N., Chang L., Ji J., Meng X.K., Zhang H.Q., Zhong Y., Yu S.P., et al. An efficient strategy for digging protein-protein interactions for rational drug design—A case study with HIF-1α/VHL. Eur. J. Med. Chem. 2022;227:113871. doi: 10.1016/j.ejmech.2021.113871. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials